definiens: means, for each BLOCKING PATENT, a product of a Party that is ( i ) based on MONITORING APPLICATIONS disclosed or claimed in any LICENSED PATENTS ( in the case ofSRX ( or ALTEA and NIMCO, in the event of any termination ofSRX 's rights to LICENSED PATENTS for MONITORING APPLICATIONS under this Agreement » or DELIVERY APPLICATIONS ( in the case of ALTEA and NIMCO ) disclosed or claimed in any LICENSED PATENTS, ( ii ) has entered clinical testing, is awaiting regulatory clearance, has obtained regulatory clearance or is commercially sold prior to the earlier of issuance or publication of the relevant BLOCKING PATENT, and ( iii ) which infringes at least one claim of the BLOCKING PATENT . For the avoidance of doubt, ( x ) a under this Section shall include families of products encompassing the same methodology ( e.g., microporation ), even if a specific product within such family would not otherwise be a BLOCKED PRODUCT, provided that ( i ) such product was already in development as evidenced by contemporaneously generated written evidence kept in the ordinary course of business and ( ii ) at least one such product within such family is otherwise a BLOCKED PRODUCT, and ( y ) a product shall be deemed to be a BLOCKED PRODUCT if it is in the same family as another BLOCKED PRODUCT except for the substitution of a drug or analyte